Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Gordon

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
The Bone & Joint Journal|September 30, 2022
CorrigendumJasper Prijs, Zhibin Liao, Soheil Ashkani-Esfahani, et al.
The Lancet. Microbe|April 22, 2023
Mucosal immune responses following a fourth SARS-CoV-2 vaccine doseOscar Bladh, Ulrika Marking, Sebastian Havervall, et al.
The Bone & Joint Journal|August 1, 2022
Artificial intelligence and computer vision in orthopaedic trauma : the why, what, and howJasper Prijs, Zhibin Liao, Soheil Ashkani-Esfahani, et al.
Bone & Joint Open|October 20, 2021
An increasing number of convolutional neural networks for fracture recognition and classification in orthopaedics : are these externally validated and ready for clinical application?Luisa Oliveira E Carmo, Anke van den Merkhof, Jakub Olczak, et al.
Transplantation and Cellular Therapy|October 1, 2020
Comorbidities Predict Inferior Survival in Patients Receiving Chimeric Antigen Receptor T Cell Therapy for Diffuse Large B Cell Lymphoma: A Multicenter AnalysisAdam S Kittai, Ying Huang, Max Gordon, et al.
The New England Journal of Medicine|September 14, 2022
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron InfectionSebastian Havervall, Ulrika Marking, Julia Svensson, et al.
Nature Communications|December 28, 2025
Plasma protein profiling predicts cancer in patients with non-specific symptomsFredrika Wannberg, María Bueno Álvez, Alvida Qvick, et al.
Clinical & Translational Immunology|April 21, 2022
Impact of SARS-CoV-2 infection on vaccine-induced immune responses over timeSebastian Havervall, Ulrika Marking, Nina Greilert-Norin, et al.
Vaccines|March 26, 2022
Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA VaccinesUlrika Marking, Sebastian Havervall, Nina Greilert-Norin, et al.
The Lancet. Infectious Diseases|June 12, 2022
Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infectionKim Blom, Ulrika Marking, Sebastian Havervall, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
The Bone & Joint Journal|September 30, 2022
CorrigendumJasper Prijs, Zhibin Liao, Soheil Ashkani-Esfahani, et al.
The Lancet. Microbe|April 22, 2023
Mucosal immune responses following a fourth SARS-CoV-2 vaccine doseOscar Bladh, Ulrika Marking, Sebastian Havervall, et al.
The Bone & Joint Journal|August 1, 2022
Artificial intelligence and computer vision in orthopaedic trauma : the why, what, and howJasper Prijs, Zhibin Liao, Soheil Ashkani-Esfahani, et al.
Bone & Joint Open|October 20, 2021
An increasing number of convolutional neural networks for fracture recognition and classification in orthopaedics : are these externally validated and ready for clinical application?Luisa Oliveira E Carmo, Anke van den Merkhof, Jakub Olczak, et al.
Transplantation and Cellular Therapy|October 1, 2020
Comorbidities Predict Inferior Survival in Patients Receiving Chimeric Antigen Receptor T Cell Therapy for Diffuse Large B Cell Lymphoma: A Multicenter AnalysisAdam S Kittai, Ying Huang, Max Gordon, et al.
The New England Journal of Medicine|September 14, 2022
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron InfectionSebastian Havervall, Ulrika Marking, Julia Svensson, et al.
Nature Communications|December 28, 2025
Plasma protein profiling predicts cancer in patients with non-specific symptomsFredrika Wannberg, María Bueno Álvez, Alvida Qvick, et al.
Clinical & Translational Immunology|April 21, 2022
Impact of SARS-CoV-2 infection on vaccine-induced immune responses over timeSebastian Havervall, Ulrika Marking, Nina Greilert-Norin, et al.
Vaccines|March 26, 2022
Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA VaccinesUlrika Marking, Sebastian Havervall, Nina Greilert-Norin, et al.
The Lancet. Infectious Diseases|June 12, 2022
Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infectionKim Blom, Ulrika Marking, Sebastian Havervall, et al.
Pageof 10